Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution-Reference-Cited by-同舟云学术

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution

Published:2019-11-18 Issue:5 Volume:55 Page:929-938
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Mamcarz Ewelina,Madden Renee,Qudeimat Amr,Srinivasan Ashok,Talleur Aimee^ORCID,Sharma Akshay^ORCID,Suliman Ali,Maron Gabriela,Sunkara Anusha,Kang Guolian,Leung Wing,Gottschalk Stephen^ORCID,Triplett Brandon M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-019-0750-7.pdf

Reference48 articles.

1. Oliansky DM, Camitta B, Gaynon P, Nieder ML, Parsons SK, Pulsipher MA, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement. Biol Blood Marrow Transplant. 2012;18:979–81. https://doi.org/10.1016/j.bbmt.2012.03.011.

2. Oliansky DM, Rizzo JD, Aplan PD, Arceci RJ, Leone L, Ravindranath Y, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. Biol Blood Marrow Transplant. 2007;13:1–25. https://doi.org/10.1016/j.bbmt.2006.10.024.

3. Brissot E, Rialland F, Cahu X, Strullu M, Corradini N, Thomas C, et al. Improvement of overall survival after allogeneic hematopoietic stem cell transplantation for children and adolescents: a three-decade experience of a single institution. Bone Marrow Transplant. 2016;51:267–72. https://doi.org/10.1038/bmt.2015.250. e-pub ahead of print 2015/12/08

4. Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, et al. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant. 2005;36:757–69. https://doi.org/10.1038/sj.bmt.1705140.

5. Holtan SG, DeFor TE, Lazaryan A, Bejanyan N, Arora M, Brunstein CG, et al. Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation. Blood. 2015;125:1333–8. https://doi.org/10.1182/blood-2014-10-609032.

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing Allogeneic Hematopoietic Stem Cell Transplantation Outcomes through Immunotherapy: A Comprehensive Review of Optimizing Non-CAR Donor T-Lymphocyte Infusion Strategies;Biomedicines;2024-08-14

2. Safety and Efficacy of High-Dose Memory CD45RO+ Donor Lymphocyte Infusion in Pediatric Recipients after Hematopoietic Stem Cell Transplantation;Cytotherapy;2024-07

3. Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial;Journal of Hematology & Oncology;2024-06-27

4. Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy;Transplantation and Cellular Therapy;2024-05

5. Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation;Cells;2024-01-11